PPD

PPD Inc.

Price

return (12m)

p/e

47.29

p/bv

-40.03

DIVIDEND YIELD

0.00%

PPD price

PPD

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment PPD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PPD

Valuation

P/E

47.29

Sector -3.10

Industry -3.10

P/BV

-40.03

Sector 1.77

Industry 1.77

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

79.05

Sector -216.68

Industry -216.68

EV/EBIT

111.70

Sector -46.14

Industry -46.14

P/EBITDA

26.86

Sector -21.54

Industry -21.54

P/EBIT

51.10

Sector -27.94

Industry -27.94

P/Total Assets

2.42

Sector 1.05

Industry 1.05

P/Net Current Assets

Sector -9.24

Industry -9.24

P/Working Capital

Sector -135.45

Industry -135.45

EPS

1.00

Sector -1.78

Industry -1.78

BVPS

-1.18

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

37.27%

Sector 41.24%

Industry 41.24%

EBITDA Margin

16.23%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

11.16%

Sector -35.37%

Industry -35.37%

Net Profit Margins

6.11%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.22

Sector 0.03

Industry 0.03

Profitability

ROE

-84.64%

Sector -57.47%

Industry -57.47%

ROA

5.11%

Sector -59.48%

Industry -59.48%

ROIC

Sector -2,385.22%

Industry -2,385.22%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 2.92

Industry 2.92

Net Debt / EBITDA

11.98

Sector -21.38

Industry -21.38

Net Debt / EBIT

16.93

Sector -8.29

Industry -8.29

Net Debt / Equity

-7.15

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

-9.91

Sector -0.84

Industry -0.84

Equity/Assets

-0.06

Sector 0.46

Industry 0.46

Liabilities/Assets

-0.06

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

5.42%

Sector -

Industry -

5Y Earnings CAGR

4.65%

Sector -

Industry -

Fundamentals PPD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PPD PPD Inc.	$0.00	-	0.00%	47.29	-40.03	-84.64%	6.11%
PFE Pfizer Inc.	$29.30	29.93%	5.91%	38.29	1.94	5.07%	6.80%
ABBV AbbVie Inc.	$283.02	27.22%	2.40%	79.71	-84.84	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.44	-25.78%	4.74%	9.57	5.08	53.11%	35.32%
MRK Merck & Co. Inc.	$144.69	75.65%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$165.06	-0.87%	1.95%	19.76	5.09	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$58.66	42.28%	4.19%	13.18	5.48	41.59%	18.87%
ZTS Zoetis Inc.	$79.45	-43.79%	2.64%	12.52	10.49	83.77%	27.69%
AMGN Amgen Inc.	$426.52	46.68%	2.29%	26.86	20.10	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$782.52	35.91%	0.47%	18.88	2.58	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$122.82	83.23%	0.00%	34.40	99.12	288.13%	24.86%
MCK McKesson Corporation	$994.67	27.04%	0.34%	25.91	-30.79	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$502.58	20.58%	0.00%	29.00	6.31	21.76%	35.00%
CAH Cardinal Health Inc.	$250.05	61.38%	0.81%	34.89	-21.95	-62.92%	0.67%
ARGX argenx SE	$820.58	-2.74%	0.00%	13.83	3.67	26.52%	25.54%
HRMY Harmony Biosciences Holdings Inc.	$37.50	44.79%	0.00%	12.22	2.22	18.14%	18.88%
BIIB Biogen Inc.	$232.87	62.85%	0.00%	41.65	1.84	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PPD - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT PPD

PPD Inc.

Average Investor10 user rating

4.0 (0 people)

United States

9 years

Founded: 2017

2020

Time since IPO - 6 years

26.000

Employees

PPD Inc. (United States) is listed on the Nasdaq and has a market capitalization of $16.99 billion, with shareholders equity totaling $-424.42 million.

The company employs approximately 26.000 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, PPD Inc. reported $5.88 billion in revenue, generating net income of $359.24 million.

Key financial metrics include a P/E ratio of 47.29, a price-to-book (P/B) ratio of -40.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PPD.

Market cap

$16.99 billion

Net worth

$-424.42 million

$-424,421,000.00

Assets

$7.03 billion

$7,028,017,000.00

Total Shares Outstanding

359.54 million

359,538,000

Average Daily Trading Volume

$1.63 million

$1,628,448.12

Sector

Health Care

Industry

Biotechnology

PPD

PPD revenue and profits

Financial Results PPD

DRAG THE FRAME TO SEE MORE DATA

PPD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.67 27,04% (12M)

P/E

25.91

0.34%

ROE

-118.84%

P/BV

-30.79

CAH - Cardinal Health

$250.05 61,38% (12M)

P/E

34.89

0.81%

ROE

-62.92%

P/BV

-21.95

ABBV - AbbVie

$283.02 27,22% (12M)

P/E

79.71

2.40%

ROE

-106.44%

P/BV

-84.84

MRK - Merck & Co.

$144.69 75,65% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$165.06 0,10% (12M)

P/E

19.76

1.95%

ROE

25.77%

P/BV

5.09

PFE - Pfizer

$29.30 29,93% (12M)

P/E

38.29

5.91%

ROE

5.07%

P/BV

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12M)

P/E

13.18

4.19%

ROE

41.59%

P/BV

5.48

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.67 27,04% (12 M)

P/L

25.91

0.34%

ROE

-118.84%

P/VP

-30.79

CAH - Cardinal Health

$250.05 61,38% (12 M)

P/L

34.89

0.81%

ROE

-62.92%

P/VP

-21.95

ABBV - AbbVie

$283.02 27,22% (12 M)

P/L

79.71

2.40%

ROE

-106.44%

P/VP

-84.84

MRK - Merck & Co.

$144.69 75,65% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$165.06 0,10% (12 M)

P/L

19.76

1.95%

ROE

25.77%

P/VP

5.09

PFE - Pfizer

$29.30 29,93% (12 M)

P/L

38.29

5.91%

ROE

5.07%

P/VP

1.94

BMY - Bristol-Myers Squibb

$58.66 42,28% (12 M)

P/L

13.18

4.19%

ROE

41.59%

P/VP

5.48

Frequently Asked Questions

What is the price of PPD (PPD) today?

The current price of PPD (PPD) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does PPD (PPD) pay dividends?

PPD (PPD) did not pay dividends over the past year.

Is PPD (PPD) a good investment?

PPD (PPD) is currently trading at $0.00 with a P/E ratio of 47.29. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy PPD (PPD) stock?

You can buy PPD (PPD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PPD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of PPD (PPD) yield today?

Over the past month, PPD (PPD) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of PPD (PPD) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PPD

PPD Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PPD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PPD WITH OTHER STOCK

ABOUT PPD

PPD Inc.

United States

9 years

2020

26.000

Financial Results PPD

PPD cash flow

Asset, Revenue and Profit Growth - PPD

PPD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions